Supplementary Material for Pfizer Oncology – May 2025 Medical Resources

Congress materials may include information for investigational products or for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Regulatory approval of investigational products or uses is dependent on the completion of the study programs and review by regulatory authorities. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information. The clinical trial information is available at www.clinicaltrials.gov. This information is current as of May 1, 2025.Enterprise Cybersecurity Solutions, Services & Training | Proofpoint USProofpoint helps protect people, data and brands against cyber attacks. Offering compliance and cybersecurity solutions for email, web, cloud, and more.